About AlphaVax
AlphaVax is a company based in Durham (United States) founded in 1997.. AlphaVax offers products and services including AlphaVaccine Platform and Cancer Immunotherapy Vaccines. AlphaVax operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alphavax Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$135.19 K (USD), Grant
May 17, 2010
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AlphaVax
AlphaVax offers a comprehensive portfolio of products and services, including AlphaVaccine Platform and Cancer Immunotherapy Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Proprietary RNA vector for developing vaccines against infectious diseases.
Vaccines targeting cancers like breast and gastrointestinal types.
Unlock access to complete
Unlock access to complete
Funding Insights of AlphaVax
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $135,193
-
First Round
First Round
(01 Jul 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2010 | Amount | Grant - AlphaVax | Valuation |
investors |
|
| Jun, 2009 | Amount | Grant - AlphaVax | Valuation |
investors |
|
| Aug, 2008 | Amount | Grant - AlphaVax | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AlphaVax
AlphaVax has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AlphaVax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AlphaVax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alphavax Comparisons
Competitors of AlphaVax
AlphaVax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AlphaVax
When was AlphaVax founded?
AlphaVax was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Where is AlphaVax located?
AlphaVax is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
What does AlphaVax do?
AlphaVax was founded in 1997 in Durham, United States, within the biotechnology sector. Vaccines targeting infectious disease prevention and cancer immunotherapy are produced by the company. Clinical trials are underway for alpha vaccine candidates against human cytomegalovirus, influenza A virus, and HIV-1. AVX901, a HER2-VRP vaccine for metastatic breast cancer, is among the products. Alphavaccine technology is out-licensed for specific disease and antigen applications to support commercialization.
Who are the top competitors of AlphaVax?
AlphaVax's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does AlphaVax offer?
AlphaVax offers AlphaVaccine Platform and Cancer Immunotherapy Vaccines.
Who are AlphaVax's investors?
AlphaVax has 2 investors. Key investors include HHS, and Military Health.